Chief Medical Officer · EyePoint, Inc. · EyePoint Pharmaceuticals, Inc.
Side
SELL
Value
$32K
Shares
2,722
Price
$11.61
Executed
Nov 11, 2025
Disclosed
Nov 12, 2025
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Nov 11 executedNov 12, 2025 disclosed
EYPT · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Ribeiro Ramiro filed this Form 4 reporting a open-market sale of EYPT on Nov 11, 2025. It became public on Nov 12, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Medical Officer
Ribeiro Ramirocik:0002013623
Issuer
EyePoint, Inc.cik:0001314102
Revision history · 0
No field has changed since this record was first ingested.
